Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy M Gulick

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Topics in Antiviral Medicine|December 30, 2015
Choosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational AgentsRoy M Gulick
Annals of Internal Medicine|May 6, 2025
PEP Rally: Updated HIV Nonoccupational Postexposure Prophylaxis Guidelines From the Centers for Disease Control and PreventionRoy M Gulick
Drugs|January 31, 2002
Structured treatment interruption in patients infected with HIV: a new approach to therapyRoy M Gulick
Current Opinion in HIV and AIDS|April 28, 2018
New HIV drugs: 2018 and beyondRoy M Gulick
Journal of Acquired Immune Deficiency Syndromes (1999)|November 4, 2010
Antiretroviral treatment 2010: progress and controversiesRoy M Gulick
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Adherence to antiretroviral therapy: how much is enough?Roy M Gulick
Infectious Disease Clinics of North America|May 16, 2007
Antiretroviral management of treatment-naive patientsRoy M Gulick
Topics in Antiviral Medicine|April 25, 2018
Investigational Antiretroviral Drugs: What is Coming Down the PipelineRoy M Gulick
Current HIV/AIDS Reports|August 11, 2005
New antiretroviral agents for the treatment of HIV infectionKristen Marks, Roy M Gulick
AIDS (London, England)|April 18, 2003
New drugs for HIV therapyRoy M Gulick, Schlomo Staszewski
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Topics in Antiviral Medicine|December 30, 2015
Choosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational AgentsRoy M Gulick
Annals of Internal Medicine|May 6, 2025
PEP Rally: Updated HIV Nonoccupational Postexposure Prophylaxis Guidelines From the Centers for Disease Control and PreventionRoy M Gulick
Drugs|January 31, 2002
Structured treatment interruption in patients infected with HIV: a new approach to therapyRoy M Gulick
Current Opinion in HIV and AIDS|April 28, 2018
New HIV drugs: 2018 and beyondRoy M Gulick
Journal of Acquired Immune Deficiency Syndromes (1999)|November 4, 2010
Antiretroviral treatment 2010: progress and controversiesRoy M Gulick
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Adherence to antiretroviral therapy: how much is enough?Roy M Gulick
Infectious Disease Clinics of North America|May 16, 2007
Antiretroviral management of treatment-naive patientsRoy M Gulick
Topics in Antiviral Medicine|April 25, 2018
Investigational Antiretroviral Drugs: What is Coming Down the PipelineRoy M Gulick
Current HIV/AIDS Reports|August 11, 2005
New antiretroviral agents for the treatment of HIV infectionKristen Marks, Roy M Gulick
AIDS (London, England)|April 18, 2003
New drugs for HIV therapyRoy M Gulick, Schlomo Staszewski
Pageof 16